sentences:
One vaccine to counter many diseases? Modelling the economics of oral polio vaccine against child mortality and COVID-19 BackgroundRecent reviews summarize evidence that some vaccines have heterologous or non-specific effects (NSE), potentially offering protection against multiple pathogens. Numerous economic evaluations examine vaccines pathogen-specific effects, but we have found only two economic evaluations of NSE. This paper starts to fill this gap by reporting economic evaluations of the NSE of oral polio vaccine (OPV) against under-five mortality and COVID-19.

MethodsWe studied two settings: (1) reducing child mortality in a high-mortality setting (Guinea-Bissau) and (2) preventing COVID-19 in India. In the former, the intervention involves three annual campaigns in which children receive OPV incremental to routine immunization. In the latter, a susceptible-exposed-infectious-recovered model was developed to estimate the population benefits of two scenarios, in which OPV would be co-administered alongside COVID-19 vaccines. Incremental cost-effectiveness and benefit-cost ratios were modelled for ranges of intervention effectiveness estimates to supplement the headline numbers and account for heterogeneity and uncertainty.

ResultsFor child mortality, headline cost-effectiveness was $650 per child death averted. For COVID-19, assuming OPV had 20% effectiveness, incremental cost per death averted was $23,000-65,000 if it were administered simultaneously with a COVID-19 vaccine less than 200 days into a wave of the epidemic. If the COVID-19 vaccine availability were delayed, the cost per averted death would decrease to $2600-6100. Estimated benefit-to-cost ratios vary but are consistently high.

ConclusionEconomic evaluation suggests the potential of OPV to efficiently reduce child mortality in high mortality environments. Likewise, within a broad range of assumed effect sizes OPV could play an economically attractive role against COVID-19.

labels: health economics


sentences:
Safety and immunogenicity of Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine against SARS-CoV-2 Omicron variant in Japanese healthcare workers BackgroundThe Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in Japan in November 2021. This variant contains up to 36 mutations in the spike protein, the target of neutralizing antibodies, and can escape vaccine-induced immunity. The third booster vaccination campaign began with healthcare workers and high-risk groups. The safety and immunogenicity of third booster vaccination against Omicrons remain unknown.

MethodsIn total, 272 healthcare workers were evaluated for their long-term safety and immunogenicity. Here, we established vaccine panels to evaluate the safety and immunogenicity against variants of concern (VOCs), including the Omicron variant, using a live virus microneutralization assay.

FindingsTwo-dose vaccination induced robust anti-spike antibodies and neutralization titers (NTs) against the ancestral strain WK-521, whereas NTs in VOCs were significantly decreased. Within 93-247 days of the second vaccine dose, NTs against Omicron were completely abolished in up to 80% of individuals among the vaccine panels. The third booster vaccination induced a robust increase in anti-spike antibodies and NTs against the WK-521, Delta, and Omicron variants. The breadth of humoral immunity and cross-reactivity with Omicron increased. The cytokine signature and adverse event rate remained unchanged after three-dose vaccination.

ConclusionsThe third vaccination dose is safe and effective against Omicron infection.

FundingThis study was supported by grants from AMED (Grant Number JP21fk0108104 and JP21mk0102146).

labels: infectious diseases


sentences:
Cannabis Use and Sleep Quality in Daily Life: a Daily Diary Study of Adults Starting Cannabis for Health Concerns BackgroundLegalization of cannabis for medical uses has proceeded without well-controlled study of its efficacy and safety for most indications. Real world patterns of medical cannabis use are highly variable and rarely overseen by a physician. Pragmatic effectiveness studies with web-based and smartphone assessment methods, designed to understand ecologically valid patterns of medical cannabis use and health symptoms, can help clarify the risks and benefits of cannabis use for medical indications.

MethodsAs part of a larger, randomized trial (NCT03224468), adults (N=181) seeking medical cannabis for insomnia, pain, or anxiety or depressive symptoms were randomized to obtain a medical cannabis card immediately (MCC) or to a waitlist control (WLC) and subsequently completed 12-weeks of daily web-based surveys on cannabis use and three health outcomes: sleep, pain, and depressive symptoms.

ResultsCompletion rates of daily surveys in this long-term, web-based survey design were moderate to high across participants (median number of daily assessments completed: 72 out of 90 days). Daily reports of cannabis use were consistent with monthly interview assessments and urinalysis. The MCC group increased cannabis use frequency in the 12 weeks following randomization, while WLC did not. Within the MCC group, self-reported sleep quality was significantly higher on cannabis use days, compared to nonuse days. The MCC group displayed long-term sleep improvements, consistent with increased cannabis frequency rather than a sustained effect of any single cannabis use. Daily associations between cannabis use and self-reported pain or depressive symptoms were small and not significant.

ConclusionCannabis use is associated with same day improvements in self-reported sleep quality, but not pain or depressive symptoms, although sleep improvements occurred in the context of increased frequency of cannabis use, raising the risk for cannabis use disorder. Long-term, daily web-based assessments of cannabis appear valid and feasible in medical cannabis users, providing a robust method for future real-world effectiveness studies with expanded and objective measures.

labels: addiction medicine


sentences:
Development of a core outcome set on traditional Chinese medicine (COS-TCM) for rheumatic heart disease (RHD): study protocol IntroductionRheumatic heart disease (RHD) is an important cause of acquired heart disease in children and adolescents globally. Clinical trials on RHD treatment with traditional Chinese medicine (TCM) are gradually increasing in China. However, because clinical trials are heterogeneous and report outcomes selectively, similar studies cannot be merged and compared, complicating assessing the effectiveness and safety of TCM, diminishes the value of clinical trials, and results in a waste of research resources. Therefore, there is an urgent need to develop a core outcome set of traditional Chinese medicine for rheumatic heart disease (COS-TCM-RHD). This study will report the protocol development process for COS-TCM-RHD.

Methods and analysisA multidisciplinary Steering Committee will lead the development of this protocol through four stages (1). Establishing a comprehensive and systematic outcomes checklist through a systematic review of previously published research, retrieval of clinical trial registration centers, patients semi-structured interviews, and clinicians questionnaire surveys; (2). Screen stakeholder groups from various fields to participate in the Delphi survey; (3). Two rounds of e-Delphi surveys will be conducted to determine the outcomes of various concerned stakeholder groups; (4). Hold a face-to-face consensus meeting to develop the COS-TCM-RHD.

Ethics and disseminationEthical approval has been granted by the Tianjin university of Traditional Chinese Medicine Ethics Committee. The findings will be published in peer-reviewed journals and the website of Chinese Clinical Trials for Core Outcome Set.

Trial registrationThis study protocol has been prospectively registered with the Core Outcome Measures in Effectiveness Trials (COMET):

http://www.comet-initiative.org/Studies/Details/1743.

Strengths and limitations of this study{blacksquare} This protocol is the first core outcomes set registered on the Core Outcome Measures in Effectiveness Trials (COMET) website for the treatment of rheumatic heart disease by Traditional Chinese medicine.
{blacksquare}This study is guided by the Core Outcome Set-STAndards for Development and Core Outcome Set-Standardized Protocol Items, with recommendations of the COMET.
{blacksquare}A multidisciplinary Steering Committee will supervise this research, and stakeholders from different fields including clinicians, patients, methodologists, and COS developers will be engaged.
{blacksquare}Systematic reviews, qualitative research (patients semi-structured interviews and clinicians questionnaire surveys), Delphi surveys, and consensus meetings will be used for core outcome set development.
{blacksquare}Traditional Chinese medicine is mainly used in China. Thus, the geographical distribution of stakeholders will be a limitation.

labels: cardiovascular medicine


sentences: Joinpoint Regression to Determine the Impact of COVID-19 on Mortality in Europe: A Longitudinal Analysis From 2000 to 2020 in 27 Countries The novel coronavirus disease 2019 (COVID-19) represented the most extensive health emergency in human history. However, to date, there is still a lot of uncertainty about the exact death toll the pandemic has claimed. In particular, the number of official deaths could be vastly underestimated. Despite this, many conspirationists speculate that COVID-19 is not a dangerous disease. Therefore, in this manuscript, we use joinpoint regression analysis to estimate the impact of COVID-19 in 27 European countries by comparing annual mortality trends from 2000 to 2020. Furthermore, we provide accessible evidence even for a non-expert audience. Siegel (A1) and Holm-Bonferroni (A2) approaches were employed to assess the significance of the results separately. In conclusion, these results estimate that COVID-19 increased the overall mortality in Europe by 10% (A1: P < .001, A2: Adjusted P = .001). In 16 out of 27 countries (59.3%), the excess mortality ranged from 7.4% to 18.5% (A1: P < .003, A2: Adjusted P < .040). Comparison of the excess mortalities distribution to the null counterfactual showed that the mortality increase was highly significant across Europe (Adjusted P < .001).

labels: epidemiology


sentences: Monitoring SARS-CoV-2 genome evolution in a localized population Despite seminal advances towards understanding its infection mechanism, SARS-CoV-2 continues to cause significant morbidity and mortality worldwide. Though mass immunization programs have been implemented in several countries, the viral transmission cycle has shown a continuous progression in the form of multiple waves. A constant change in the frequencies of dominant viral lineages, arising from the accumulation of nucleotide variations (NVs) through favourable selection, is understandably expected to be a major determinant of disease severity and possible vaccine escape. Indeed, worldwide efforts have been initiated to identify specific virus lineage(s) and/or NVs that may cause a severe clinical presentation or facilitate vaccination breakthrough. Since host genetics is expected to play a major role in shaping virus evolution, it is imperative to study role of genome-wide SARS-CoV-2 NVs across various populations. In the current study, we analysed the whole genome sequence of 3543 SARS-CoV-2 infected samples obtained from the state of Telangana, India (including 210 from our previous study), collected over an extended period from April, 2020 to October, 2021. We present a unique perspective on the evolution of prevalent virus lineages and NVs during this time period. We also highlight presence of specific NVs likely to be associated favourably with samples classified as vaccination breakthroughs. Finally, we report genome-wide intra-host variations (iSNVs) at novel genomic positions. The results presented here provide critical insights into virus evolution over an extended time period within a geographically restricted area and pave the way to rigorously investigate the role of specific NVs in vaccination breakthroughs.


sentences:
Loneliness is associated with mentalizing and emotion recognition abilities in schizophrenia, but only in a cluster of patients with social cognitive deficits. BackgroundLoneliness is a concern for patients with schizophrenia (SCZ). However, the correlates of loneliness in SCZ are unclear; thus, the aim of the study is to investigate neuro- and social cognitive (SC) mechanisms associated with loneliness in SCZ.

MethodsData for the study were pooled from two cross-national samples (Poland/USA) and included 147 SCZ and 103 healthy controls (HC) overall. Data from clinical, neurocognitive, and SC assessments were examined as potential predictors of loneliness in HC and SCZ samples pooled across two sites. Furthermore, Latent Class Analysis (LCA) was used to cluster patients based on SC capacity. Next, the relationship between SC and loneliness was explored in each cluster of SCZ.

ResultsSCZ reported higher levels of loneliness than HC. Loneliness was linked to increased negative and affective symptoms in patients. A negative association between loneliness and mentalizing and emotion recognition abilities was found in the patients with social-cognitive impairments, but not in those who performed at normative levels.

ConclusionsWe have elucidated a novel mechanism which may explain previous inconsistent findings regarding the correlates of loneliness in SCZ. As decreased SC capacity may be linked with loneliness only in patients with observable SC impairments, SC heterogeneity in SCZ needs to be recognized while planning psychosocial interventions targeting loneliness in this group.

labels: psychiatry and clinical psychology


sentences:
Prevalence of Specific Multimorbidity Combinations and Association with Medical Expenditures and Perceived Health among U.S. Adults, 2016-2019 BackgroundMultimorbidity is common, but the prevalence and burden of the specific combinations of co-occurring disease has not been systematically examined at the population level in the U.S. The objective was to identify and measure the burden of highly prevalent combinations of chronic conditions treated among adults in the United States.

MethodsCross-sectional analysis of U.S. households in the Medical Expenditure Panel Survey (MEPS), 2016-2019, a large nationally-representative sample of the community-dwelling population. Association rule mining was used to identify the most common combinations of 20 chronic conditions that have high relevance, impact, and prevalence in primary care. The main measures and outcomes were annual treated prevalence, total medical expenditures, and perceived fair/poor health.

ResultsFrequent pattern mining yielded 259 unique combinations of chronic disease, including 77 two-way (dyad), 134 three-way (triad), 47 four-way, and one five-way combinations that are treated in one million or more U.S. adults. {Hypertension & Hyperlipidemia} was the most common two-way combination. The combination of {Diabetes & Arthritis & Cardiovascular disease} was associated with the highest median annual medical expenditures ($23,850, [Interquartile range: $11,593 - $44,616]), and the combination of {Diabetes & Arthritis & Asthma/COPD} had the highest age-race-sex adjusted odds ratio of fair/poor self-rated health (adjusted odd ratio: 6.9, [95%CI: 5.4 - 8.8]).

ConclusionThis study demonstrates that many multimorbidity combinations are highly prevalent among U.S. adults, yet most research and practice-guidelines remain single disease focused. Highly prevalent and burdensome multimorbidity combinations could be prioritized for evidence-based research on optimal prevention and treatment strategies.

labels: public and global health


sentences: Microbial GWAS studies revealing combinations of Omicron RBD mutations existed and may contribute to antibody evasion and ACE2 binding Since Omicron variant of SARS-CoV-2 was first detected in South Africa (SA), it has now dominated in United Kingdom (UK) of Europe and United State (USA) of North America. A prominent feature of this variant is the gathering of spike protein mutations, in particularly at the receptor binding domain (RBD). These RBD mutations essentially contribute to antibody resistance of current immune approaches. During global spillover, combinations of RBD mutations may exist and synergistically contribute to antibody resistance in fact. Using three geographic-stratified genome wide association studies (GWAS), we observed that RBD combinations exhibited a geographic pattern and genetical associated, such as five common mutations in both UK and USA Omicron, six or two specific mutations in UK or USA Omicron. Although the UK specific RBD mutations can be further classified into two separated sub-groups of combination based on linkage disequilibrium analysis. Functional analysis indicated that the common RBD combinations (fold change, -11.59) alongside UK or USA specific mutations significantly reduced neutralization (fold change, -38.72, -18.11). As RBD overlaps with angiotensin converting enzyme 2(ACE2) binding motif, protein-protein contact analysis indicated that the common RBD mutations enhanced ACE2 binding accessibility and were further strengthened by UK or USA-specific RBD mutations. Spatiotemporal evolution analysis indicated that UK-specific RBD mutations largely contribute to global spillover. Collectively, we have provided genetic evidence of RBD combinations and estimated their effects on antibody evasion and ACE2 binding accessibility.


sentences:
Race-adjusted Lung Function Increases Inequities in Diagnosis and Prognosis and Should Be Abandoned BackgroundLung function assessment is essential for respiratory medicine and health. Recommended international reference values differ by race, which is controversial. We evaluated the effect of adjusting lung function for race on prevalence of lung function impairment, breathlessness and mortality in the US population.

MethodsPopulation-based analysis of the National Health and Nutrition Examination Survey (NHANES) 2007-2012. Race was analyzed as black, white, or other. Lung function was assessed as forced expired volume in one second (FEV1) and forced vital capacity (FVC). Predicted normal values were calculated for each person using the Global Lung Initiative (GLI)-2012 equations for 1) white; 2) black; and 3) other/mixed populations. Outcomes were compared for the different reference values in relation to: prevalence of lung function impairment (<lower limit of normal [LLN]), moderate/severe impairment (<50%pred); self-reported exertional breathlessness; and mortality up to 31 December, 2015.

FindingsWe studied 14,123 people (50% female); white (n=5,928), black (n=3,130), and other (n=5,065). Compared to those for white, black reference values identified markedly fewer cases of lung function impairment (FEV1) both in black people (9.3% vs. 36.9%) and other non-white races (1.5% vs. 9.5%); and prevalence of moderate/severe impairment was approximately halved. Outcomes among those impaired differed by reference value used: white (best outcomes), other/mixed (intermediate), and black (worst outcomes). Black people with FEV1 [≥]LLNblack but <LLNwhite had 48% increased rate of breathlessness and almost doubled mortality, compared to blacks [≥]LLNwhite. Lung function [≥]LLNwhite identified people with good outcomes, similarly in black and white people. Findings were similar when analyzing FEV1 or FVC.

InterpretationRace adjustment of lung function should be abandoned. White reference values are most sensitive and specific to identify impairment, and could be applied across the population for improved assessment and health equity.

FundingSwedish Research Council (Dnr: 2019-02081).

Research in contextO_ST_ABSEvidence before this studyC_ST_ABSWe searched MEDLINE and Embase using search terms including "race", "ethnicity", "pulmonary function", "spirometry", and "prediction equations" from database inception and January 10, 2022, for papers published in English. A total 33 papers related to lung function and race were identified. Race-adjusted lung function reference values were recommended by major guidelines for use internationally. Race-specific references assume a 10-15% lower lung function, such as the forced expired volume in one second (FEV1) and forced vital capacity (FVC), in black people and 4-6% lower in Asian people compared with in whites. Compared to not adjusting for race, race-adjusted lung function values have recently been questioned as they have been found to not improve prediction of outcomes in population-based studies or in people at risk of obstructive pulmonary disease. Concerns have been raised that, contrary to the intent, race-adjusted reference values may contribute to under diagnosis of disease in disadvantage minorities, with the largest differences reported in black (Afro-American) people, and may worsen race-related health inequalities. Data on the impact of race-adjusted lung function values across the ethnically diverse population are limited and data on how to decrease racial bias in lung function assessment are needed.

Added value of this studyWe analyzed the impact of using different race-specific (GLI-2012) reference equations for FEV1 and FVC across the US population in the National Health and Nutrition Examination Survey (NHANES) 2007-2012. Outcomes were prevalence of lung function impairment (value < lower limit of normal), breathlessness on exertion, and mortality up to December 31, 2015. Compared to using references for whites, black reference values were less likely to identify lung function impairment across all races but especially in blacks (9.3% vs. 36.9%); and those identified had lower lung function, more breathlessness, and worse prognosis. Black people with lung function normal by black standards but impaired by white standards had increased prevalence of breathlessness and mortality, compared to those normal also by white standards. Thus, race-adjusted reference values labeled black people as normal despite worse outcomes. White normal values identified people with similarly good lung function, and low rates of breathlessness and mortality across races groups.

Implications of all the available evidenceThe findings from this study support that race-adjusted reference values markedly under diagnose lung function impairment, and related breathlessness, and mortality in underprivileged groups across the US population. Normal values for whites were most sensitive to identify lung function impairment related to worsening outcomes and people classified as having normal lung function with similar good outcomes irrespective of race group. These findings suggest that lung function should not be adjusted for race. When applied across the population, white reference values were most sensitive to identify smaller or earlier impairment and most specific to identify people with normal lung function with similarly good outcomes across race groups. Given the large impact shown, abandoning the use of race-adjusted lung function values is likely to contribute to improved health equity.

labels: respiratory medicine


sentences:
Association between oral health and hyperuricemia in Korean adults: Korea National Health and Nutrition Examination Survey 2016-2019 Hyperuricemia plays an essential role in the development of gout. Despite the clinical importance of hyperuricemia, a direct relationship between oral health and hyperuricemia has not been established. Therefore, we aim to investigate the association between oral health and hyperuricemia in Korean adults.

We selected 17,584 subjects from the Korea National Health and Nutrition Examination Survey 2016-2019 database. Oral health-related variables included the number of dental caries, regular tooth brushing, use of secondary oral products, and regular dental examination. The odds ratio (OR) and 95% confidence intervals (CIs) for hyperuricemia were calculated using a multivariable-adjusted logistic regression model.

In all subjects, oral health status with dental caries and oral health behaviors, including tooth brushing; secondary oral products; and regular dental examination, were significantly associated with hyperuricemia. The adjusted OR and 95% CIs for hyperuricemia comparing more than three dental caries with no dental caries were 1.28 (1.08-1.51). The adjusted OR and 95% CIs for hyperuricemia in regular tooth brushing, use of secondary oral products, and regular dental examination were 0.78 (0.67-0.91), 0.91 (0.82-1.00), and 0.86 (0.78-0.95), respectively. Notably, the association between oral health and hyperuricemia was more prominent in male subjects. In addition, when subjects were grouped by the scoring system regarding oral health, the prevalence of hyperuricemia was lower in groups with a better oral health score.

In conclusion, we demonstrated that oral health status and behaviors were associated with hyperuricemia, especially in males. Further complementary studies are needed to confirm the definite association between oral health and hyperuricemia.

labels: rheumatology


sentences:
Discrepancy review: A feasibility study of a novel peer review intervention to reduce undisclosed discrepancies between registrations and publications BackgroundUndisclosed discrepancies often exist between study registrations and their associated publications. Discrepancies can increase risk of bias, and when undisclosed, they disguise this increased risk of bias from readers. To remedy this issue, we developed an intervention called discrepancy review. We provided journals with peer reviewers specifically assigned to check for undisclosed discrepancies between registrations and manuscripts submitted to journals.

ObjectivesWe aimed to (1) evaluate the feasibility of incorporating discrepancy review as a regular practice at scientific journals and the feasibility of conducting a trial on discrepancy review; (2) explore the benefits and time required to incorporate discrepancy review as a regular practice at scientific journals; and (3) refine the discrepancy review process.

MethodWe performed discrepancy review on 18 manuscripts submitted to Nicotine and Tobacco Research and 3 manuscripts submitted to the European Journal of Personality. We iteratively refined the discrepancy review process based on feedback from discrepancy reviewers, editors, and authors. We then assessed whether revised manuscripts addressed recommendations from discrepancy reviewers and identified potential outcome measures for use in a future trial of discrepancy review.

ResultsRegistrations were generally too imprecise to be effectively evaluated by our original discrepancy review process so we developed a simplified, semi-structured process. Authors addressed the majority of discrepancy reviewer comments and there was no opposition to running a trial from authors, editors, or discrepancy reviewers. Clinical trial registrations were more precise but less comprehensive than registrations on the Open Science Framework, suggesting they should be evaluated in separate trials. Outcome measures for a trial of discrepancy review on clinical trial registration could include the presence of primary or secondary outcome discrepancies and whether publications that are not the primary report from a clinical trial registration are clearly described as such. Outcome measures for a trial on Open Science Framework registrations could include assessments of whether registrations are permanent, as well as an overarching subjective assessment of the impact of discrepancies.

ConclusionWe found that discrepancy review could feasibly be introduced as a regular practice at journals interested in this process. A full trial of discrepancy review would be needed to evaluate its impact on reducing undisclosed discrepancies.

labels: health systems and quality improvement


sentences:
Is trait mindfulness associated with lower pain reactivity and connectivity of the default mode network? A replication and extension study in healthy and episodic migraine participants Formal training in mindfulness-based practices promotes reduced experimental and clinical pain, which may be driven by reduced emotional pain reactivity and undergirded by alterations in the default mode network (DMN), implicated in mind-wandering and self-referential processing. Recent results published in this journal suggest that trait mindfulness (TM), or the day-to-day tendency to maintain a non-reactive mental state in the absence of training, associates with reduced pain reactivity, pain sensitivity, and resting-state DMN functional connectivity (FC) in healthy adults in a similar manner to trained mindfulness. The extent to which these findings extend to chronic pain samples and replicate in healthy samples is unknown. Using data from healthy adults (n = 36) and episodic migraine patients (n = 98) and replicating previously published methods, we observed no significant association between TM and pain sensitivity (r = -0.05, p = .80), intensity (r = .01, p = .94) or unpleasantness (r = .07, p = .67), or pain catastrophizing (PC; r = .30, p = .08) in healthy controls, or between TM and headache frequency (r = -.11, p = .26), severity (r = .03, p = .77), impact (r = -.17, p = .10) or PC (r = -0.09, p = .36) in patients. There was no association between DMN connectivity and TM in either sample when probed via seed-based FC analyses. In post-hoc whole brain exploratory analyses, meta-analytically derived DMN nodes (i.e., PCC and vmPFC) showed connectivity with regions unassociated with pain processing as a function of TM, such that healthy adults higher in TM showed greater PCC-cerebellum and vmPFC-parietal FC. Collectively, these findings suggest that the relationship between TM and DMN-FC may be nuanced or lacking in robustness, and cast doubt on TM as a clinically meaningful protective factor in migraine.

PerspectiveThis study tested relationships between trait mindfulness and pain, pain reactivity and default mode connectivity in healthy adults and migraine patients. Findings cast doubt on trait mindfulness as an individual difference marker of the ability to cope with pain in healthy adults, and as a protective factor in episodic migraine.

labels: pain medicine


sentences:
Performance of five metagenomic classifiers for virus pathogen detection using respiratory samples from a clinical cohort Viral metagenomics is increasingly being applied in clinical diagnostic settings for detection of pathogenic viruses. While a number of benchmarking studies have been published on the use of metagenomic classifiers for abundance and diversity profiling of bacterial populations, studies on the comparative performance of the classifiers for virus pathogen detection are scarce.

In this study, metagenomic data sets (N=88) from a clinical cohort of patients with respiratory complaints were used for comparison of the performance of five taxonomic classifiers: Centrifuge, Clark, Kaiju, Kraken2, and Genome Detective. A total of 1,144 positive and negative PCR results for a total of 13 respiratory viruses were used as gold standard. Sensitivity and specificity of these classifiers ranged from 83-100% and 90-99% respectively, and was dependent on the classification level and data pre-processing. Exclusion of human reads generally resulted in increased specificity. Normalization of read counts for genome length resulted in minor overall performance, however negatively affected the detection of targets with read counts around detection level. Correlation of sequence read counts with PCR Ct-values varied per classifier, data pre-processing (R2 range 15.1-63.4%), and per virus, with outliers up to 3 log10 reads magnitude beyond the predicted read count for viruses with high sequence diversity.

In this benchmarking study, sensitivity and specificity were within the ranges of use for diagnostic practice when the cut-off for defining a positive result was considered per classifier.

HighlightsO_LIThe performance of five metagenomic classifiers was assessed using datasets obtained from respiratory samples from a clinical cohort of patients
C_LIO_LI88 samples were characterized by means of 1,144 respiratory virus PCR results
C_LIO_LIUsing PCR as gold standard, sensitivity and specificity ranged from 83-100% and 90-99% respectively, with the overall highest scores resulting from amino-acid based classification by Kaiju classifier. Performance was dependent on classification level and exclusion of human reads prior to classification.
C_LIO_LINormalization of assigned read counts for corresponding genome lengths generally had minor effect on performance, but negatively affected the detection of target viruses with read counts around detection level.
C_LIO_LICorrelation between sequence read counts and PCR Ct-values varied per classifier (12.1-62.7% at species level), per data pre-processing, and per virus. Outliers were detected of up to 3 log10 reads the predicted read counts for viruses with high sequence diversity.
C_LIO_LISensitivity and specificity of the classifiers were within the range of use for diagnostic practice when combined with a determined cut-off for defining a positive result.
C_LI


sentences:
Combination of Spironolactone and Sitagliptin Improves Clinical Outcomes of Outpatients with COVID-19: An Observational Study BackgroundCoronavirus disease 2019 (COVID-19) leads to hospitalization and death, especially in elderly and those with comorbidities. There are evidences showing that sitagliptin and spironolactone can potentially improve the clinical outcomes of COVID-19 cases. In this observational study on acutely symptomatic outpatient COVID-19 cases, we investigated the effects of spironolactone and sitagliptin on the outcomes of the disease.

MethodsThis prospective cohort study was conducted at Shiraz University of Medical Sciences Clinics during the fifth wave of the COVID-19 pandemic between July 2021 and September 2021. We followed mild to moderate symptomatic COVID-19 patients, who were treated with either combination (spironolactone 100 mg daily and sitagliptin 100 mg daily) or standard (steroid, antiviral and/or supportive care) therapy up to 30 days. Our primary outcome was hospitalization rate. The secondary outcomes included ER visit, duration of disease, and complications, such as hypoglycemia, low blood pressure or altered mental status.

ResultsOf the 206 patients referred to clinics, 103 received standard therapy and 103 treated with combination therapy. There were no significant differences in baseline characteristics, except for slightly higher clinical score in control group (6.92 {+/-} 4.01 control, 4.87 {+/-} 2.92 combination; P <0.0001). Treatment with combination therapy was associated with lower admission rate (5.8% combination, 22.3% control; P = 0.0011), ER visits (7.8% combination, 23.3% control; P = 0.0021) and average duration of symptoms (6.67 {+/-} 2.30 days combination, 18.71 {+/-} 6.49 days control; P =<0.0001).

ConclusionIn this prospective cohort study of acutely ill outpatients with COVID-19, the combination of sitagliptin and spironolactone reduced duration of COVID infection and hospital visits better than standard therapeutic approaches. The effects of combination of sitagliptin and spironolactone in COVID-19 patients should be further verified in a double blind, randomized, placebo-controlled trial.


sentences:
Effectiveness of the EPA-based 'Toolbox Family Medicine' on students' learning satisfaction: study protocol for a controlled trial BackgroundFamily practices constitute an important learning environment for medical students. However, teaching situations markedly vary between practices, and students frequently find rotations underwhelming. Especially, students active participation in patient care varies profoundly, although it has a significant impact on students interest in primary care careers. To standardize and improve learning situations in practices, we developed the so-called  Toolbox Family Medicine (TFM) using the concept of entrustable professional activities. It provides standardized learning content appropriate for students levels and allows teaching adaptable to actual practice conditions.

MethodsUsing a controlled trial with a waiting list control arm, we will evaluate the effectiveness of the toolbox on students learning satisfaction. A total of 94 students will be allocated 1:1 to intervention and control practices. The teaching concept  Toolbox Family Medicine (TFM) comprises a didactic workshop for supervising physicians and a toolbox with practice-specific tasks for medical students. The primary outcome is students overall satisfaction with their learning progress after the rotation. Secondary outcomes include the kind and number of tasks performed, the entrusted level per task, the feasibility of implementing the toolbox in actual practice settings, and students motivation to pursue a career in primary care.

DiscussionWe assume an improvement in learning satisfaction with the intervention. The study will begin with the next practice rotations.

Administrative information

O_TBL View this table:
org.highwire.dtl.DTLVardef@1854ffborg.highwire.dtl.DTLVardef@1460a5eorg.highwire.dtl.DTLVardef@152d543org.highwire.dtl.DTLVardef@12f4f85org.highwire.dtl.DTLVardef@10dcc59_HPS_FORMAT_FIGEXP  M_TBL C_TBL

labels: medical education


sentences:
Pregnancy outcomes and long-term patient and graft survival after kidney transplantation IntroductionKidney transplant is considered the method of choice in the treatment of end-stage chronic kidney disease, improving survival and quality of life, and often allowing the recovery of fertility among woman. Objective: This study aims to assess the outcomes of post-transplant pregnancy, newborn and patient graft survival, compared to a control group of transplanted women who werent pregnant.

MethodsA retrospective case-control study was conducted at the Kidney Transplant Service of Santa Casa de Misericordia in Porto Alegre, among 1.253 female patients who underwent kidney transplantation and were of childbearing age between 1977 and 2016. They were compared to a control group matched for age, type of donor, date of transplant and immunological risk.

Results76 (6,1%) of the patients became pregnant, resulting in a total of 93 pregnancies. Compared to the control group, at 10 years after transplantation there was no significant difference in relation to graft loss (74% vs 66%, p=0.524), and the survival of pregnant patients was higher (97% vs 79%, p=0.018). We found that 40% pregnancies progressed to abortion, 30% of the deliveries were preterm, and 26% happened at term. Three pregnancies progressed to stillbirth. Of the 56 pregnancies that evolved, 23 (41%) resulted in pre-eclampsia, and one in eclampsia.

Conclusion6,1% of the women in the study became pregnant, and 56% of these pregnancies were successful. Compared to the control group, we found that those who got pregnant had similar graft survival outcomes and longer patient survival.

labels: nephrology


sentences:
The organisation of nurse staffing in intensive care units: a qualitative study AimsTo examine the organisation of the nursing workforce in intensive care units and identify factors that influence how the workforce operates.

BackgroundPre-pandemic UK survey data show that up to 60% of intensive care units (ICUs) did not meet locally agreed staffing numbers and 40% of ICUs were closing beds at least once a week because of workforce shortages, specifically nursing. Nurse staffing in ICUs is based on the assumption that sicker patients need more nursing resource than those recovering from critical illness. These standards are based on historical working, and expert professional consensus, deemed the weakest form of evidence.

MethodsFocus groups with health care professionals working in ICUs (n= 52 participants) and individual interviews with critical care network leads and policy leads (n= 14 participants) in England between December 2019 and July 2020. Data were analysed using framework analysis.

FindingsThree themes were identified: the constraining or enabling nature of ICU and hospital structures; whole team processes to mitigate nurse staffing shortfalls; and the impact of nurse staffing on patient, staff and ICU flow outcomes. Staff made decisions about staffing throughout a shift and were influenced by a combination of factors illuminated in the three themes.

ConclusionsWhilst nurse: patient ratios were clearly used to set the nursing establishment, it was clear that rostering and allocation/re-allocation during a shift took into account many other factors, such as patient and family nursing needs, staff wellbeing, ICU layout and the experience, and availability, of other members of the multi-professional team. This has important implications for future planning for ICU nurse staffing and highlights important factors to be accounted for in future research studies.

Implications for Nursing ManagementThe potential opportunities for different staffing models are likely to be highly dependent on other professions. Hence, any change to staffing models needs to take into account how different professions work together.

Factors such as ICU layout, reported to influence nurse staffing decisions, suggest that patient safety in ICU may not be best served by blanket  ratio approaches to nurse staffing, intended to apply uniformly across health services.

The findings have the potential to feed into discussions about funding tariffs for critical care and quality metrics to be included in commissioning contracts.

labels: nursing


sentences:
mRNA-COVID19 vaccination can be considered safe and tolerable for frail patients BackgroundFrail patients are considered at relevant risk of complications due to COVID-19 infection and, for this reason, are prioritized candidates for vaccination. As these patients were originally not included in the registration trials, fear related to vaccine side-effects and disease worsening was one of the reasons for vaccine hesitancy. Herein we report the safety profile of the prospective, multicenter, national VAX4FRAIL study (NCT04848493) to evaluate vaccines in a large trans-disease cohort of patients with solid or hematological malignancies, neurological and rheumatological diseases.

MethodsBetween March 3rd and September 2nd, 2021, 566 patients were evaluable for safety endpoint: 105 received the mRNA-1273 vaccine and 461 the BNT162b2 vaccine.

Frail patients were defined per protocol as patients under treatment with hematological malignancies (131), solid tumors (191), immune-rheumatological diseases (86), and neurological diseases (158), including multiple sclerosis and generalized myasthenia.

The impact of the vaccination on the health status of patients was assessed through a questionnaire focused on the first week after each vaccine dose.

ResultsThe most frequently reported moderate-severe adverse events were pain at the injection site (60.3% after the first dose, 55.4% after the second), fatigue (30.1% - 41.7%), bone pain (27.4% - 27.2%) and headache (11.8% - 18.9%).

Risk factors associated with the occurrence of severe symptoms after vaccine administration were identified through a multivariate logistic regression analysis: age was associated with severe fever presentation (younger patients vs. middle-aged vs. older ones), females presented a higher probability of severe pain at the injection site, fatigue, headache, and bone pain; the mRNA-1237 vaccine was associated with a higher probability of severe pain at the injection site and fever. After the first dose, patients presenting a severe symptom were at a relevant risk of recurrence of the same severe symptom after the second one.

Overall, 11 patients (1.9%) after the first dose and 7 (1.2%) after the second one required to postpone or suspend the disease-specific treatment. Finally, 2 fatal events occurred among our 566 patients. These two events were considered unrelated to the vaccine.

ConclusionsOur study reports that mRNA-COVID-19 vaccination is safe also in frail patients as expected side effects were manageable and had a minimum impact on patient care path.

ImportanceOur study reports the safety analysis of the trial VAX4FRAIL confirming that mRNA-COVID-19 vaccination is safe in frail immunocompromised patients: expected side effects were manageable and had a minimum impact on patient care path.

ObjectiveTo evaluate the safety of mRNA-COVID-19 vaccination in vulnerable patients.

DesignVAX4FRAIL is a national, multicentric, observational, prospective trial (start date March 3rd, 2021 - primary completion date September 2nd, 2021).

SettingMulticenter prospective trial.

ParticipantsFrail patients were defined per protocol as patients under treatment with solid tumors (191), immune-rheumatological diseases (86), hematological malignancies (131), and neurological diseases (158), including multiple sclerosis and generalized myasthenia.

ExposureOverall, 105 received the mRNA-1273 vaccine and 461 the BNT162b2 vaccine.

Main OutcomeThe occurrence of adverse events after 1st and 2nd m-RNA-COVID-19 vaccination was analyzed. Adverse events were collected through a questionnaire comprising both open and closed questions.

ResultsThe most frequently reported moderate-severe adverse events were pain at the injection site (60.3% after the first dose, 55.4% after the second), fatigue (30.1% - 41.7%), bone pain (27.4% - 27.2%) and headache (11.8% - 18.9%).

Risk factors associated with the occurrence of severe symptoms after vaccine administration were identified through a multivariate logistic regression analysis: age was associated with severe fever presentation (younger patients vs. middle-aged vs. older ones), females presented a higher probability of severe pain at the injection site, fatigue, headache, and bone pain; the mRNA-1237 vaccine was associated with a higher probability of severe pain at the injection site and fever. Patients presenting a severe symptom after the first dose were at a relevant risk of recurrence of the same severe symptom after the second one.

Overall, 11 patients (1.9%) after the first dose and 7 (1.2%) after the second one was required to postpone or suspend their disease-specific treatment. Finally, 2 fatal events occurred among our 566 patients, and these two events were due to disease progression and considered unrelated to the vaccine.

Conclusion and RelevanceOur study reports that mRNA-COVID-19 vaccination is safe also in frail patients as expected side effects were manageable and had a minimum impact on patient care path.

Study RegistrationA National, Multicentric, Observational, Prospective Study to Assess Immune Response to COVID-19 Vaccine in Frail Patients (VAX4FRAIL). NCT04848493 https://clinicaltrials.gov/ct2/show/NCT04848493

Key PointsO_ST_ABSQuestionC_ST_ABSCan m-RNA-COVID19 vaccination be considered safe for frail patients?

FindingsIn this national, multicentric, observational, prospective trial (NCT04848493) that included 566 frail patients, the occurrence of both local and systemic adverse events was manageable and did not negatively impact on the general treatment program.

MeaningmRNA-COVID19 vaccination is safe among frail immunocompromised patients.

labels: oncology


sentences:
Outcomes of the Advanced Visualization In Corneal Surgery Evaluation (ADVISE) trial; a non-inferiority randomized control trial to evaluate the use of intraoperative OCT during Descemet membrane endothelial keratoplasty PurposeTo evaluate if an intraoperative OCT (iOCT) optimized surgical protocol without prolonged overpressure is non-inferior to a standard protocol during Descemet membrane endothelial keratoplasty (DMEK).

DesignA multicenter international prospective non-inferiority randomized control trial

SubjectsSixty-five pseudophakic eyes of 65 patients with corneal endothelial dysfunction resulting from Fuchs endothelial corneal dystrophy were enrolled in 3 corneal centers in The Netherlands and Belgium.

MethodsThe study was powered to include 63 patients scheduled for routine DMEK. Subjects were randomized to the control arm (n=33) without iOCT-use and raising the intraocular pressure above normal physiological limits for 8 minutes (i.e., overpressure) or the intervention arm (n=32) with OCT-guidance to assess graft orientation and adherence while refraining from prolonged raising the intraocular pressure. The RD and 95% confidence intervals (95% CI) were calculated from a logistic regression model using 1,000 bootstrap samples. Secondary outcomes included the incidence of graft detachment, surgeon-reported iOCT-aided surgical decision making, surgical time, endothelial cell density (ECD), and corrected distance visual acuity (CDVA).

Main Outcome MeasuresThe primary outcome was the incidence of postoperative surgery-related adverse events, defined as rebubbling, graft failure, and iatrogenic acute glaucoma. The non-inferiority margin was set at a risk difference (RD) of 10%.

ResultsIn the control group, 13 adverse events were recorded in 10 subjects compared to 13 adverse events in 12 subjects in the intervention group. The mean unadjusted RD measured 0.38% (95%CI: - 9.64-10.64) and the RD adjusted for study site measured -0.32% (95%CI: -10.29-9.84). No significant differences in ECD and CDVA were found between the two groups 3 and 6 months postoperatively. Surgeons reported that iOCT aided surgical decision-making in 40% of cases. Surgical- and graft unfolding time were, respectively, 13% and 27% shorter in the iOCT-group.

ConclusionsiOCT-guided DMEK surgery with refraining from prolonged over-pressuring was non-inferior compared to conventional treatment. Surgery times were reduced considerably, and surgeons reported the iOCT aided surgical decision-making in 40% of cases. Refraining from prolonged overpressure did not affect postoperative ECD or CDVA.

labels: ophthalmology


sentences:
The SENSOR System: Using Standardized Data Entry and Dashboards for Review of Scientific Studies Using the Clinical Applications of Psychedelics as an Illustration IntroductionLiterature reviews are useful tools for communicating the breadth of scientific discovery for a given topic. Irrespective of the nature of the review, data should be communicated in effective, easy to understand ways. In trying to address these limitations of traditional scientific reviews, we propose using dynamic data driven displays that have been used in multiple other industries to improve communication and decision making. Given the recent interest in the clinical applications of psychedelics for various mental health issues, we chose to test the SENSOR System (Standardized Data Entry and Dashboards for Review of Scientific Studies) as an alternative for an existing review article.

MethodsTo validate the SENSOR System, an existing review with a topical, heterogenous, and growing set of studies was selected. In this case we chose the Wheeler et al. review on psychedelics in clinical practice where articles had already been preselected and reviewed. Detailed discussion of this review and the cited papers preceded designing the content and shared links for a Google Form for data intake, Google Drive for article access, and Google Sheets linked to the form intake data.

ResultsA total of 46 study entries were made by 2 team members, including 3 articles published since the review to demonstrate the ease of updating the system Various representations of the Google Forms intake data in the SENSOR System dashboard are presented.

DiscussionVisual representation of review studies using a dashboard proved feasible and advantageous for numerous reasons. As the technology and guidelines for these systems evolve there is an opportunity to standardize reporting, centralize legacy datasets, streamline the submission process, improve collaboration between researchers, measure relative contribution of participating authors, and improve patient involvement. For the use case of clinical applications of psychedelics, limitations of conveying data accurately includes heterogeneity of study design, dosing, indications, and outcome measures.

ConclusionCreation of a system for standardized data entry and dashboards for reviews of scientific studies is a feasible alternative and/or adjunct to the dissemination of summaries through traditional scientific review. There are numerous proposed advantages of the flexible, dynamic, and graphical display that requires further validation.

labels: health informatics


sentences: Investigating sensitivity of nasal or throat (ISNOT): A combination of both swabs increases sensitivity of SARS-CoV-2 rapid antigen tests The COVID-19 pandemic has been hallmarked by several waves of variants of concern (VoCs), each with novel challenges. Currently, the highly transmissible Omicron VOC is predominant worldwide, and sore throat is common among other cold-like symptoms. Anecdotes on social media suggested sampling ones throat can increase sensitivity for Omicron detection by antigen-based rapid testing devices (Ag-RDTs). This work determines whether the sensitivity of Ag-RDTs designed for nasal sampling is altered with use of self-administered throat swabs in self-perceived asymptomatic individuals. This investigation compared results of a common Ag-RDT (i.e. Abbott Panbio COVID-19 Ag Rapid Test Device) using three sampling sites: nasal swab; throat swab and; combined nasal/throat. All Ag-RDT results were confirmed with molecular testing. Compared to RT-PCR, samples from nasal or throat swabs each detected 64.5% of SARS-CoV-2 cases; however, combining the contributions of each swab increased sensitivity to 88.7%. This trend was also evident with the Rapid Response Ag-RDT (BTNX), which uses a more flexible swabs than Panbio. When nasal swab collection was compared to paired sampling of the nasal/throat using a single swab with the Panbio Ag-RDT, the sensitivity of each was 68.4% and 81.6%, respectively. No false-positive results were observed with nasal, throat, or combined nasal/throat sampling. Self-administered throat and nasal/throat swabs both had >90% acceptability. These findings support the use of self-collected combined nasal/throat sampling for Ag-RDT based SARS-CoV-2 detection in self perceived asymptomatic individuals.


sentences:
An expanded high throughput RT-PCR assay to rapidly identify all known SARS-CoV-2 variants of concern using melting temperature coding. BackgroundThe rapid emergence of new vaccine-resistant SARS-CoV-2 variants of concern (VOC) requires an equally rapid deployment of diagnostic tests to specifically identify each VOC as soon as it arises. Here, we report an expanded version of our previously described sloppy molecular beacon (SMB) Alpha/Beta/Gamma RT-PCR melting temperature (Tm) signature-based assay, which now includes modifications that allow specific detection of Delta (B.1.617.2) and Omicron (B.1.529) VOCs.

MethodsWe developed a dual SMB assay (SMB-452), which targeted the T22917G (L452R) mutation in the SARS-CoV-2 spike protein to specifically detect the Delta VOC. We also identified a Tm profile in our existing SMB-501 and SMB-484 assays (which detect mutations in codons 501 and 484 of the SARS-CoV-2 spike protein, respectively) that differentiate the Omicron-specific N501Y (A23063T) and E484A (A23013C) mutations from both wild type (WT) and other VOCs. The entire six SMB three-codon assay was tested using reference SARS-CoV-2 RNAs. The assay was then validated using clinical samples from COVID-19 patients tested with a LightCycler 480 (LC480) (74 samples), Bio-Rad CFX96 (34 samples), Rotor-Gene Q (Qiagen) (34 samples) and an ABI-7500 (34 samples) RT-PCR instruments. Six SMB Tm results were then inputted into an Excel Analysis tool to generate specific VOC identifications.

ResultsThe limit of detection (LOD) for the new SMB-452 assay, which specifically identified the Delta variant was 1 genomic equivalent (GE) per reaction. The LODs of the SMB-501 and SMB-484 assays, which detect Omicron were 100 and 103 GE respectively. Clinical validation of the 3-codon assay in the LC480 instrument showed the assay detected 94% of the samples as WT or VOCs in clinical samples and 6% of the tests producing indeterminate results. None of the samples were incorrectly identified as WT or as a different VOC. Thus, excluding samples with indeterminant results, the assay was 100% sensitive and 100% specific compared to sequencing. There was also 100% concordance between the LC480, BioRad, ABI and Qiagen results, excluding negative or indeterminate results; however, the Qiagen assay had significantly more indeterminates than the other assays.

ConclusionThis new assay can serve as a robust diagnostic tool for selecting appropriate monoclonal antibody therapy and rapid VOC surveillance.


sentences:
Testing behaviour may bias observational studies of vaccine effectiveness BackgrounRecent observational studies have suggested that vaccines for the omicron variant of SARS-Cov2 may have little or no effect in preventing infection. However, the observed effects may be confounded by patient factors and preventive behaviours or vaccine-related differences in testing behaviour. To assess the potential degree of confounding, we aimed to estimate differences in testing behaviour between unvaccinated and vaccinated populations.

MethodsWe recruited 1,526 Australian adults for an online randomised study about COVID testing between October and November 2021, and collected self-reported vaccination status and three measures of COVID-19 testing behaviour. We examined the association between testing intentions and vaccination status in the cross-sectional baseline data of this trial.

ResultsOf the 1,526 participants (mean age 31 years): 22% had a COVID-19 test in the past month and 61% ever; 17% were unvaccinated, 11% were partially vaccinated (1 dose), 71% were fully vaccinated (2+ doses). Fully vaccinated participants were twice as likely (RR 2.2; 95% CI 1.8 to 2.8) to report positive COVID testing intentions than those who were unvaccinated (p<.001). Partially vaccinated participants had less positive intentions than those fully vaccinated (p<.001) but higher intentions than those who were unvaccinated (p=.002).

DiscussionFor all three measures vaccination predicted greater COVID testing intentions. If the unvaccinated tested at half the rate of the vaccinated, a true vaccine effectiveness of 30% could appear to be a "negative" observed vaccine effectiveness of -40%. Assessing vaccine effectiveness should use methods to account for differential testing behaviours. Test negative designs are currently the preferred option, but its assumptions should be more thoroughly examined.


sentences:
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 boosters against SARS-CoV-2 Omicron (B.1.1.529) infection in Qatar BACKGROUNDWaning of COVID-19 vaccine protection and emergence of SARS-CoV-2 Omicron (B.1.1.529) variant have expedited efforts to scale up booster vaccination. This study compared protection afforded by booster doses of the BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccines, compared to the primary series of only two doses in Qatar, during a large, rapidly growing Omicron wave.

METHODSIn a population of 2,232,224 vaccinated persons with at least two doses, two matched, retrospective cohort studies were implemented to investigate effectiveness of booster vaccination against symptomatic SARS-CoV-2 infection and against COVID-19 hospitalization and death, up to January 9, 2022. Association of booster status with infection was estimated using Cox proportional-hazards regression models.

RESULTSFor BNT162b2, cumulative symptomatic infection incidence was 2.9% (95% CI: 2.8-3.1%) in the booster-dose cohort and 5.5% (95% CI: 5.3-5.7%) in the primary-series cohort, after 49 days of follow-up. Adjusted hazard ratio for symptomatic infection was 0.50 (95% CI: 0.47-0.53). Booster effectiveness relative to primary series was 50.1% (95% CI: 47.3-52.8%). For mRNA-1273, cumulative symptomatic infection incidence was 1.9% (95% CI: 1.7-2.2%) in the booster-dose cohort and 3.5% (95% CI: 3.2-3.9%) in the primary-series cohort, after 35 days of follow-up. The adjusted hazard ratio for symptomatic infection was 0.49 (95% CI: 0.43-0.57). Booster effectiveness relative to primary series was 50.8% (95% CI: 43.4-57.3%). There were fewer cases of severe COVID-19 in booster-dose cohorts than in primary-series cohorts, but cases of severe COVID-19 were rare in all cohorts.

CONCLUSIONSmRNA booster vaccination is associated with modest effectiveness against symptomatic infection with Omicron. The development of a new generation of vaccines targeting a broad range of variants may be warranted.


sentences: Thyroid hormone axis and anthropometric recovery of children/adolescents with overweight/obesity: a scoping review Thyroid hormones play multiple physiological effects essential for the maintenance of basal metabolic rate (BMR), adaptive thermogenesis, fat metabolism, and appetite. The links between obesity and the hormones of the thyroid axis, i.e., triiodothyronine (T3), thyroxine (T4), thyrotropin-releasing hormone (TRH), and thyrotropin (TSH), are still controversial, especially when considering children and adolescents. This population has high rates of overweight and obesity and several treatment approaches, including nutritional, psychological, and physical exercise interventions have been used. Understanding the importance of the hormones of the thyroid axis in the recovery from overweight and obesity may help directing measures to the maintenance of a healthy body composition. The present scoping review was carried out to analyze studies evaluating these hormonal levels throughout interventions directed at treating overweight and obesity in children and adolescents. The main purpose was to ascertain whether the hormones levels vary during weight loss. We selected for analysis 16 studies published between 1999 and 2019. Most of the studies showed that the changes in body composition parameters in response to the multidisciplinary interventions correlated positively with free T3 (fT3)/ total T3 (TT3)/TSH. With respect to free T4 (fT4)/ total T4 (TT4), the most common finding was of unchanged levels and hence, no significant association with weight loss. Importantly, the response to the intervention has even been found to not be affected by fT4 supplementation. Further studies are necessary to elucidate the relevance of the variations in hormone levels to the establishment of overweight/obesity and to the recovery from these conditions in children/adolescents.

labels: pediatrics


sentences:
A mixed method study on supportive supervision of Community Health Workers from Central India IntroductionSupportive supervision of the Community health workers (CHWs) are critical for their efficient functioning in various health programs. CHWs in India are supervised by facilitators known as ASHA Sahyogini. Our study aimed at investigating the linkage between knowledge and skills of CHW facilitators and their CHWs. To understand the problems encountered by the CHW facilitators while assisting their CHWs. Also, to determine the perceptions of CHWs on nature of supportive supervision of their facilitators.

MethodsA mixed method explanatory study using purposive sampling was conducted in a rural block of Madhya Pradesh (Central India). The CHWs were categorised into relatively high performing (RHP) and relatively low performing (RLP) groups based on their performance-based incentives received during (2017-2018). Quantitative component comprised of self-administered questionnaire and skill assessment while the qualitative component comprised of three focussed group discussion with RHP, RLP CHWs and their facilitators.

ResultsThe mean (SD) supportive supervision score given by CHW facilitators were found to be significantly associated with CHWs performance. Problems faced by CHW facilitators while assisting their CHWs resulted from inadequate education of CHWs, insufficient incentives, transport problems and repetitive surveys. While some CHWs perceived to have received good assistance from their facilitators, there were a few who were not dependant on their facilitators and executed duties by self.

ConclusionCHWs performance cannot be ascribed completely to the CHW facilitators performance. The challenges perceived by CHW facilitators were unmodifiable and requires them to strongly motivate and support their CHWs in order to improve their functionality.

labels: primary care research


sentences:
DRAGON-Data: A platform and protocol for integrating genomic and phenotypic data across large psychiatric cohorts IntroductionCurrent psychiatric diagnoses, although heritable, have not been clearly mapped onto distinct underlying pathogenic processes. The same symptoms often occur in multiple disorders, and a substantial proportion of both genetic and environmental risk factors are shared across disorders. However, the relationship between shared symptomatology and shared genetic liability is still poorly understood. Well-characterised, cross-disorder samples are needed to investigate this matter, but currently few exist, and severe mental disorders are poorly represented in existing biobanking efforts. Purposely curated and aggregated data from individual research groups can fulfil this unmet need, resulting in rich resources for psychiatric research.

Methods and analysesAs part of the Cardiff MRC Mental Health Data Pathfinder, we have curated and harmonised phenotypic and genetic information from 15 studies within the MRC Centre for Neuropsychiatric Genetics and Genomics to create a new data repository, DRAGON-DATA. To date, DRAGON-DATA includes over 45,000 individuals: adults or children with psychiatric diagnoses, affected probands with family members and individuals who carry a known neurodevelopmental copy number variant (ND-CNV). We have processed the available phenotype information to derive core variables that can be reliably analysed across groups. In addition, all datasets with genotype information have undergone rigorous quality control, imputation, CNV calling and polygenic score generation.

Ethics and DisseminationDRAGON-DATA combines genetic and non-genetic information and is available as a resource for research across traditional psychiatric diagnostic categories. Its structure and governance follow standard UK ethical requirements (at the level of participating studies and the project as a whole) and conforms to principles reflected in the EU data protection scheme (GDPR). Algorithms and pipelines used for data harmonisation are currently publicly available for the scientific community, and an appropriate data sharing protocol will be developed as part of ongoing projects (DATAMIND) in partnership with HDR UK.


sentences:
The rapid identification and diagnosis of meniscus injuries by Magnetic Resonance Imaging using a deep learning model ObjectiveThe meniscus tear is a common problem in sports trauma. The imaging diagnosis mainly depends on the MRI. To improve the diagnostic accuracy and efficiency, a deep learning model was employed in this study and the identification efficiency has been evaluated.

MethodsThe standard knee MRI images of 924 individual patients were used to complete the training, validation, and testing process. The Mask R-CNN was considered as the deep learning network structure, and the ResNet50 was considered as the backbone network. The deep learning model was trained and validated with a dataset containing 504 and 220 patients, respectively. The accuracy testing was performed on a dataset of 200 patients and reviewed by an experienced radiologist and a sports medicine physician.

ResultsAfter training and validation, the deep learning model effectively recognized the healthy and injured meniscus. The overall average precision of the bounding box and pixel mask was more than 88% when the IoU threshold value was 0.75. The detailed average precision of three types of menisci (healthy, torn, and degenerated) was ranged from 68% to 80%. The overall sensitivity of the bounding box and pixel mask was more than 74% at the IoU threshold from 0.50 to 0.95. The diagnosis accuracy for the healthy, torn, and degenerated meniscus was 87.50%, 86.96%, and 84.78%, respectively.

ConclusionThe Mask R-CNN recognized effectively and predicted the meniscus injury, especially for the tears that occurred at different parts of the meniscus. The recognition accuracy was admirable. The diagnostic accuracy can be further improved with the increase of the training sample size. Therefore, this tool has great potential in the application for the diagnosis of meniscus injury.

The translational potential of this articleDeep learning model has unique effect in reducing doctors workload and improving diagnosis accuracy. It can identify and classify injured and healthy meniscus more accurately after training and learning datasets. The torn and degenerated meniscus can also be distinguished by this model. This technology could serve as an effective tool for clinical MRI-assisted diagnostics in meniscus injury.

labels: radiology and imaging


sentences:
RNAseq of amniotic fluid cell-free RNA: insights into the pathophysiology of congenital cytomegalovirus infection BackgroundCongenital cytomegalovirus (cCMV) is the most common perinatal infection and a significant cause of sensorineural hearing loss, cerebral palsy and neurodevelopmental disability. There is a paucity of human gene expression studies examining the pathophysiology of CMV infection.

ObjectivesThe aim of this study was to perform a whole transcriptomic assessment of amniotic fluid from pregnancies with live fetuses to identify differentially-expressed genes and enriched Gene Ontology categories associated with cCMV infection.

Study designAmniotic fluid supernatant was prospectively collected from pregnant women undergoing amniocentesis for suspected cCMV due to first trimester maternal primary infection or ultrasound features suggestive of fetal infection. Women who had received therapy to prevent fetal infection were excluded. cCMV was diagnosed via viral PCR of amniotic fluid; CMV-infected fetuses were paired with noninfected controls, matched for gestational age and fetal sex. Paired-end RNA sequencing was performed on amniotic fluid cell-free RNA with the Novaseq6000 at a depth of 30 million reads/sample. Following quality control and filtering, reads were mapped to the human genome and counts summarised across genes. Differentially expressed genes were identified using two approaches: voomWithQualityWeights in conjunction with limma and RUVSeq with edgeR. Genes with a false discovery rate (FDR) < 0.05 were considered statistically significant. Differential exon usage was analysed using DEXSeq. Functional analysis was performed using Gene Set Enrichment Analysis and Ingenuity Pathway Analysis. Manual curation of differentially regulated genes was also performed.

ResultsAmniotic fluid samples were collected from 50 women; 16 (32%) had cCMV confirmed by PCR. After excluding 3 samples without matched controls, 13 CMV-infected samples collected at 18-23 weeks and 13 CMV-negative gestation matched controls were submitted for RNA sequencing and analysis (total n=26). Ten of the 13 pregnancies with CMV-infected fetuses had amniocentesis due to serological evidence of maternal primary infection with normal fetal ultrasound, and three had amniocentesis due to ultrasound abnormality suggestive of CMV infection. Four CMV-infected pregnancies ended in termination (n=3) or fetal death (n=1), and 9 resulted in live births. Pregnancy outcomes were available on 11 of the 13 CMV-negative controls; all resulted in live births of clinically-well infants.

Differential gene expression analysis revealed 309 up-regulated and 32 down-regulated genes in the CMV-infected group compared with the CMV-negative group. Gene set enrichment analysis showed significant enrichment of multiple Gene Ontology categories involving the innate immune response to viral infection and interferon signalling. Of the 32 significantly down-regulated genes, 8 were known to be involved in neurodevelopment and preferentially expressed by the brain. Six specific cellular restriction factors involved in host defence to CMV infection were upregulated in the CMV-infected group. Ingenuity Pathway Analysis predicted activation of pathways involved in  progressive neurological disease, and  inflammatory neurological disease.

ConclusionsIn this next generation sequencing study, we reveal new insights into the pathophysiology of cCMV infection. These data on the upregulation of the intraamniotic innate immune response to CMV infection and the dysregulation of neurodevelopmental genes may inform future approaches to developing prognostic markers and assessing fetal responses to in utero therapy.

labels: obstetrics and gynecology


sentences:
Corneal cisterns as drainage aqueducts ImportanceAnterior chamber paracentesis (ACP) is a known method of rapid reduction of IOP. The mechanism of how corneal fluid clears after ACP is not well described.

ObjectiveTo determine the mechanism of instantaneous corneal clearing of edema after ACP.

Design, setting, and participantsThis case series includes consecutive patients with high IOP and associated corneal edema, who presented to the Glaucoma Services of our tertiary care center. Pre- and post-intervention (ACP) ASOCTs were analyzed.

Main outcome measuresResolution of corneal edema (clinical picture) and imaging of peripheral cornea and iridocorneal angle area.

ResultsTen consecutive patients who underwent an ACP were included in this study. The mean IOP pre-intervention was 48.4 {+/-} 8.2 mmHg. ASOCT showed ill-defined conventional pathways of aqueous outflow, which were blocked by peripheral anterior synechiae in 4 eyes. Immediately post ACP, the IOP was 16.3 {+/-} 5.6 mmHg (p < 0.001) and corneal edema resolved immediately. We found on ASOCT, that the intrastromal hypolucency of the peripheral cornea, (corneal cistern) which was limited in extent and U shaped, showed a posterior extension into the corneo-limbal junction to form well-defined anastomoses with the conventional aqueous drainage channels demonstrating a direct conduit for intracorneal fluid to egress. In 2/10 eyes, Schlemms canal opened intracamerally as well, suggesting direct reflux of intra-corneal fluid into the anterior chamber.

Conclusion and RelevanceAfter an ACP, in eyes with corneal edema to relieve IOP, we observed that the intracorneal cisterns undergo peripheral extension to drain corneal fluid through the conventional distal outflow channels.


sentences:
Association of Age-Related Macular Degeneration With Mortality: A Propensity Score-Matched Analysis PurposeTo investigate the association between age-related macular degeneration (AMD) and 10-year all-cause and cause-specific mortality using a large-scale population-based sample.

MethodsData from the 2005-2008 cycles of the National Health and Nutrition Examination Survey were used to assess the risk of mortality in relation to AMD in a propensity score-matched cohort. AMD status was assessed by retinal images with the standardized grading scheme. Mortality data until 31st December 2015 were derived from mortality archives. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for survival.

ResultsA total of 4691 participants were included. After a median follow-up of 8.42 (IQR: 7.58-9.67) years, 698 participants died. Participants with any AMD had an increased risk of all-cause mortality (HR, 2.02; 95% CI, 1.37-2.98). Similar results were observed for early (HR, 1.93; 95% CI, 1.31-2.85) and late AMD (HR, 4.29; 95% CI, 2.10-8.79). For cause-specific mortality, any (HR, 2.17; 95% CI, 1.39-3.39), early (HR, 2.18; 95% CI, 1.36-3.51), and late AMD (HR, 3.95; 95% CI, 1.65-9.46) were associated with significantly higher mortality due to causes other than cardiovascular disease (CVD) or cancer. Late AMD independently predicted a higher risk of CVD mortality (HR, 2.48; 95% CI, 1.32-4.65).

ConclusionsThe current study showed that any, early, and late AMD were associated with increased risks of all-cause mortality and mortality due to causes other than CVD or cancer. In addition, we found that late AMD was associated with increased risks of CVD mortality.

SynopsisLate macular degeneration independently predicted higher cardiovascular disease mortality. Any, early and late age-related macular degeneration were associated with higher all-cause mortality and mortality due to causes other than cardiovascular disease or cancer.


sentences:
Protocol for a Systematic Review to validate or not, the philosophic explanation under the mechanism of action of the Tension Band Wiring to estabilizase an Olecranon fracture. Olecranon fractures in young people are commonly treated surgically. When a transverse pattern is presented the most used method to fix the fracture is the Tension Band Wiring. The AO Foundation proposed a theory for the mechanism of action of this device. It could transform the tensile forces on the posterior side into compression forces on the joint side during flexion of the elbow. Our objective is to systematically review the available literature in order to confirm or not this hypothesis.

We will include biomedical research studies evaluating Tension Band Wiring function. We are planning to search on Medline, Embase and other sources including grey literature. The studies will be selected and the data extracted. Results will include a descriptive analysis and a meta-analysis to compare the observed compression force before and after the flexion of the elbow.

Our findings will be discussed having in mind the potentially clinical implications of results.

labels: orthopedics


sentences:
Persistent delirium in older hospital patients: an updated systematic review and meta-analysis IntroductionPersistent delirium is recognised as a substantial problem, but there are few insights into which patient groups might be particularly affected. Delirium is associated with future dementia progression. Yet whether this occurs subclinically over months and years, or persistent delirium merges into worsened dementia is not understood.

MethodsWe adopted an identical approach to a previous systematic review, only including studies using a recognised diagnostic framework for ascertaining delirium at follow-up (persistent delirium). We applied risk of bias assessments based on Standards of Reporting of Neurological Disorders criteria. Estimates were pooled across studies using random-effects meta-analysis, and we estimated associations with age and follow-up duration using meta-regression.

ResultsWe identified 13 new cohorts, which we added to 8 from the previous systematic review (21 relevant studies reporting persistent delirium over 37 time points). Studies were mainly at low risk of bias. Pooled delirium prevalence estimates at discharge were 40% (95% CI 24% to 54%, 10 studies). Meta-regression showed variation in prevalence of persistent delirium over time (0.6% per week, 95% CI -1.2 to -0.1, p=0.02). Older study sample age was associated with higher prevalence of persistent delirium (8.8% per SD age, 95% CI 1.1% to 17%). The rate of improvement was the same regardless of age, but the overall burden was higher with older age such that 44% (95% CI 11% to 76%) of 95-year-olds would be expected to have persistent delirium at 12 months.

ConclusionsThis systematic review emphasises the key importance of delirium as a persistent and extensive problem, particularly in the oldest-old. Addressing persistent delirium will require a whole-system, integrated approach in order to detect, follow-up and implement opportunities for recovery across all healthcare settings.

labels: geriatric medicine


sentences:
The economic burden of low back pain in KwaZulu-Natal, South Africa: a prevalence-based cost-of-illness analysis from the healthcare provider's perspective. BackgroundGlobally, low back pain (LBP) is associated with high economic costs due to healthcare expenditure and production loss. There is lack of evidence regarding this in low-and-middle-income-countries (LMICs), including South Africa. Thus, the study aimed to determine the economic burden of LBP from the providers perspective.

MethodsWe used a retrospective prevalence-based cost-of-illness methodology to estimate the direct medical cost of LBP. Direct medical costs constituted costs associated with healthcare utilisation in inpatient care, outpatient care, investigations, consultations, and cost of auxiliary devices. We used diagnostic-specific data obtained from hospital clinical reports. All identifiable direct medical costs were estimated using a top-down approach for costs associated with healthcare and a bottom-up approach for costs associated with inpatient and outpatient care.

ResultsThe prevalence of CLBP was 24.3% (95% CI: 23.5 - 25.1). The total annual average direct medical costs associated with LBP was US$5.4 million. Acute LBP and CLBP contributed 17% (US$0.92 million) and 83% (US$4.48 million) of the total annual average direct medical cost, respectively. The per patient total annual average direct medical cost for acute LBP and CLBP were US$99.43 and US$1,516.67, respectively. The total average cost of medication per patient for acute and CLBP were US$82.53 and US$320.31, respectively. Overall, the outpatient care costs contributed the largest share (38.9%, US$2.10 million) of the total average direct medical cost, 54.9% (US$1.15 million) of which was attributed to NSAIDs and only 10% (US$0.21 million) of the total outpatient cost was due to rehabilitation. The total average cost of diagnostic investigations was estimated at US$831,595.40, which formed 15.4% of the average total cost.

ConclusionThe economic burden of LBP is high in South Africa. Majority of costs were attributed to CLBP. Action should be taken to develop culturally validated cost-effective prevention measures to mitigate the burden of LBP.

labels: health economics


sentences: Social disparities in unplanned 30-day readmission rates after hospital discharge in patients with chronic health conditions: A retrospective cohort study using patient level hospital administrative data linked to the population census in Switzerland Unplanned readmissions shortly after discharge from hospital are common in chronic diseases. The risk of readmission has been shown to be related both to hospital care, e.g., medical complications, and to patients resources and abilities to manage the chronic disease at home and to make appropriate use of outpatient medical care. Despite a growing body of evidence on social determinants of health and health behaviour, little is known about the impact of social and contextual factors on readmission rates. The objective of this study was to analyse possible effects of educational, financial and social resources of patients with different chronic health conditions on unplanned 30 day-readmission risks. The study made use of nationwide inpatient hospital data that was linked with Swiss census data. The sample included n=62,109 patients aged 25 and older, hospitalized between 2012 and 2016 for one of 12 selected chronic conditions. Multivariate logistic regressions analysis was performed. Our results point to a significant association between social factors and readmission rates for patients with chronic conditions. Patients with upper secondary education (OR=1.26, 95% CI: 1.11, 1.44) and compulsory education (OR=1.51, 95% CI: 1.31, 1.74) had higher readmission rates than those with tertiary education when taking into account demographic, social and health status factors. Having private or semi-private hospital insurance was associated with a lower risk for 30-day readmission compared to patients with mandatory insurance (OR=0.81, 95% CI: 0.73, 0.90). We did not find a general effect of social resources, measured by living with others in a household, on readmission rates. The risk of readmission for patients with chronic conditions was also strongly predicted by type of chronic condition and by factors related to health status, such as previous hospitalizations before the index hospitalization (+77%), number of comorbidities (+15% higher probability per additional comorbidity) as well as particularly long hospitalizations (+64%). Stratified analysis by type of chronic condition revealed differential effects of social factors on readmissions risks. Compulsory education was most strongly associated with higher odds for readmission among patients with lung cancer (+142%), congestive heart failure (+63%) and back problems (+53%). We assume that low socioeconomic status among patients with chronic conditions increases the risk of unplanned 30-day readmission after hospitalisation due to factors related to their social situation (e.g., low health literacy, lower financial possibilities), which may negatively affect cooperation with care providers and adherence to recommended therapies as well as hamper active participation in the medical process and the development of a shared understanding of the disease and its cure. Higher levels of comorbidity in socially disadvantaged patients can also make appropriate self-management and use of outpatient care more difficult. Our findings suggest a need for increased preventive measures for disadvantaged populations groups to promote early detection of diseases and to remove financial or knowledge-based barriers to medical care. Socially disadvantaged patients should also be strengthened more in their individual and social resources for coping with illness.


sentences:
Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan BackgroundTo determine the safety profile of Sinopharm COVID-19 vaccine and identify breakthrough infections.

MethodThe study design was analytical cross sectional. An online questionnaire was filled by 1033 respondentsbetween 16th and 22nd April 2021. Adults who had received both doses of Sinopharm COVID-19 vaccine more than a week ago or only a single dose with serious side effect were included in the study. The frequency and severity of vaccination related side effects were assessed and breakthrough infection identified.

ResultsThe mean age of participants was 36.7 {+/-} 12.91(18 - 92) years. Ninety one percent of participants (n=946) were health care professionals. One fifth (n=225/1033, 21.8%) had suffered from COVID-19 infection prior to vaccination, confirmed using the nasal RT-PCR test. None of the participants reported serious (grade III) or life threatening (grade IV) adverse reactions after either of the two doses. The most common side effects after the first dose were pain at injection site (20.3%), fatigue (20.3%), headache (13.9%), myalgia (12.5%) and fever (9.3%) whereas after the second dose were fatigue (16.8%), pain at injection site (15.8%), myalgia (14%) and fever (6.7%). The side effects were more common in participants who had previous history of COVID-19 infection. Of 225 previously infected participants, 97(43.1%) (p value=0.020) and 90 (40%) (p value=0.001) participants had side effects after 1st and 2nd dose respectively. 16 participants (1.55%) developed PCR positive COVID-19 infection two weeks after the second dose while 3(0.29%) participants had a re-infection. There was one case of probable severe COVID-19 infection, 2 weeks after the second dose and recovered completely with treatment.

ConclusionOur study shows that Sinopharm COVID-19 vaccine is generally safe with no serious side effects. The side effects were however, more common in inviduals who already had COVID-19 infection. The COVID-19 breakthrough infection and reinfection could occur after the vaccination.

labels: infectious diseases


sentences: SARS-CoV-2 surveillance (09/2020 - 03/2021) in elementary schools and daycare facilities in Bavaria Here we report our results of a multi-center, open cohort study ("COVID-Kids-Bavaria") investigating the distribution of SARS-CoV-2 among children and staff in 99 daycare facilities and 48 elementary schools in Bavaria, Germany. Overall, 2568 children (1337 school children, 1231 preschool children) and 1288 adults (466 teachers, 822 daycare staff) consented to participate in the study and were randomly tested in three consecutive phases (September/October 2020, November/December 2020, March 2021). In total, 7062 throat swabs were analyzed for SARS-CoV-2 by RT-PCR. In phase I, only one daycare worker tested positive. In phase II, SARS-CoV-2 was detected in three daycare workers, two preschool children, and seven school children. In phase III, no sample tested positive. This corresponds to a positive test rate of 0.05% in phase I, 0.4% in phase II and 0% in phase III. After phase III, antibody testing was offered to 713 study participants in elementary schools. A seroprevalence rate of 7.7% (students) and 4.5% (teachers) was determined. We conclude that during the initial waves of the SARS-CoV-2 pandemic, the risk of a positive SARS-CoV-2 result correlated positively with the local 7-day incidence. Thus, an increased risk of SARS-CoV-2 transmission in the setting of daycare and elementary schooling was unlikely.


sentences: Seroprevalence of anti-SARS coronavirus 2 antibodies in Thai adults during the first three epidemic waves This study sought to determine the anti-SARS-CoV-2 antibody status of 4111 Thai people from May 2020 to April 2021, a period which spanned the first two and part of the third epidemic wave of the COVID-19 in Thailand. Participants comprised 142 COVID-19 patients, 2113 individuals at risk due to their occupations [health personnel, airport officers, public transport drivers, and workers in entertainment venues (pubs, bars and massage parlors)], 1856 individuals at risk due to sharing workplaces or living communities with COVID-19 patients, and 553 Thai citizens returning after extended periods in countries with a high disease prevalence. All sera were tested in a microneutralization assay and a chemiluminescence immunoassay (CLIA) for IgG against the N protein. Furthermore, we performed an immunofluorescence assay to resolve discordant results between the two assays. Antibody responses developed in 88% (15 of 17) of COVID-19 patients at 8 days and in 94-100% between 15 and 60 days after disease onset. Neutralizing antibodies persisted for at least 8 months, longer than the IgG did, against the N protein. None of the health providers, airport officers, and public transport drivers were seropositive, while the antibodies were present in 0.44% of entertainment workers. This study showed the seropositivity of 1.9, 1.5, and 7.5% during the 3 epidemic waves, respectively, in Bangkok residents who were at risk due to sharing workplaces or communities with COVID-19 patients. Also, antibody prevalence was 1.3% in Chiang Mai people during the first epidemic wave, and varied between 6.5 and 47.0% in Thais returning from high-risk countries. This serosurveillance study found a low infection rate of SARS-CoV-2 in Thailand before the emergence of the Delta variant in late May 2021. The findings support the Ministry of Public Healths data, which are based on numbers of patients and contact tracing.


sentences:
Effectiveness of COVID-19 Vaccines in preventing Infectiousness, Hospitalization and Mortality: A Historical Cohort Study Using Iranian Registration Data During Vaccination program BackgroundThere are some concerns about the effectiveness of the inactivated and vector-based vaccines against SARS-CoV-2 in the real-world settings with the emergence of new mutations, especially variants of concern. Data derived from administrative repositories during mass-vaccination campaigns or programs are of interest to study vaccine effectiveness (VE).

MethodsUsing 4-repository administrative data linkage, we conducted a historical cohort study on a target population of 3,628,857 inhabitants aged at least 18 years residing in Southern Iran.

ResultsWe estimated 71.9% [95% CI: 70.7-73.1%], 81.5% [95% CI: 79.5-83.4%], 67.5% [95% CI: 59.5-75.6%], and 86.4% [95% CI: 84.1-88.8%] hospitalization reduction for those who received the full vaccination schedule of BIBP-CorV, ChAdOx1-S/nCoV-19, rAd26-rAd5, and BIV1-CovIran vaccines, respectively. A high reduction in mortality - at least 85% - was observed in all age subgroups of fully immunized population.

ConclusionThe pragmatic implementation of a vaccination plan including all available vaccine options in the Iranian population was associated with a significant reduction in documented COVID-19 infection, hospitalization, and death associated with COVID-19.

Key pointsThe mass vaccination program with implementing a group of vaccines, that even for some of them (rAd26-rAd5, and BIV1-CovIran vaccines) have been only regionally authorized for emergency use, has been associated with a dramatic reduction in documented COVID-19 infection, as well as in hospitalization and deaths related to the COVID-19 diagnosis.


sentences: Human influenza virus infection elicits distinct patterns of monocyte and dendritic cell mobilization in blood and the nasopharynx During respiratory viral infections, the precise roles of monocytes and dendritic cells (DCs) in the nasopharynx in limiting infection and influencing disease severity are incompletely described. We studied circulating and nasopharyngeal monocytes and DCs in healthy individuals and in patients with mild respiratory infections (primarily influenza A virus, IAV). As compared to healthy controls (HCs), patients with acute IAV infection displayed reduced DC but increased intermediate monocytes frequencies in blood, and an accumulation of most monocyte and DC subsets in the nasopharynx. IAV patients had more mature monocytes and DCs in the nasopharynx, and higher levels of TNF, IL-6 and IFN in plasma and the nasopharynx. In blood, monocytes, the most frequent cellular source of TNF during IAV infection, remained responsive to additional stimulation with TLR7/8L. Immune responses in older patients skewed towards increased monocytes rather than DCs suggesting a contributory role for monocytes in disease severity. In patients with other respiratory virus infections, we observed changes in monocyte and DC frequencies in the nasopharynx distinct from IAV patients, while differences in blood were more similar across patient groups. Together, our findings demonstrate tissue-specific and pathogen-specific patterns of monocyte and DC function during human respiratory viral infections and highlight the importance of comparative investigations in blood and the nasopharynx.

labels: allergy and immunology


sentences:
CSF sphingomyelin metabolites in Alzheimer's disease, neurodegeneration, and neuroinflammation INTRODUCTIONSphingomyelin (SM) levels have been associated with Alzheimers disease (AD), but the association direction has been inconsistent and research on cerebrospinal fluid (CSF) SMs has been limited by sample size, breadth of SMs examined, and diversity of biomarkers available.

METHODSLeveraging two longitudinal AD cohorts with metabolome-wide CSF metabolomics data (n=502), we analyzed the relationship between the levels of 12 CSF SMs, and AD diagnosis and biomarkers of pathology, neurodegeneration, and neuroinflammation using logistic, linear, and linear mixed effects models.

RESULTSNo SMs were significantly associated with AD diagnosis, mild cognitive impairment, or amyloid biomarkers. Phosphorylated tau, neurofilament light, -synuclein, neurogranin, soluble triggering receptor expressed on myeloid cells 2, and chitinase-3-like-protein 1 were each significantly, positively associated with at least 5 of the SMs.

DISCUSSIONThe associations between SMs and biomarkers of neurodegeneration and neuroinflammation, but not biomarkers of amyloid or diagnosis of AD, point to SMs as potential biomarkers for neurodegeneration and neuroinflammation that may not be AD-specific.

labels: epidemiology


sentences:
Determinants of Late Initiation for Antenatal Care Follow up Among Pregnant Mothers Attending Public Health Centers at Jimma Town, South West Ethiopia, 2021: Unmatched Case Control Study. BackgroundWorld Health Organization recommends that, a woman without complications should have at least four antenatal care visits, the first of which should take place during the first trimester (not > 16 weeks). But, high proportion of pregnant women in most of developing countries attended first ANC at a late time. In Ethiopia, magnitude of late ANC follow up initiation is 64% and in study area 68.7% however determinants of the problem were not identified particularly in the study area.

ObjectiveTo identify determinants of late antenatal care initiation among pregnant women attending antenatal care in public health centers of Jimma town, south west Ethiopia 2021.

MethodsFacility based unmatched case control study was conducted from May 1-30. The cases (n=177) were mothers who attended their first antenatal care visit at >= 16 weeks of gestational age and the controls (n=177) were mothers who attended their first antenatal care visit at <16 weeks of gestational age during the data collection period. Data was collected through face to face interview using pre tested structured questionnaire. Descriptive and summary statistics was done. Bivariable and multivariable logistic regression analysis was done using SPSS version 21.0 to identify candidate variables at P-value <0.25 and determinants of late ANC initiation at P-value <0.05 respectively.

ResultsThe current study identified that, being age > 25 years (AOR= 2.623, 95% CI 1.059 - 6.496), poor knowledge about ANC (AOR= 3.856, 95% CI 1.266-11.750), lack of history of abortion (AOR= 3.326, 95% CI 1.082-10.224), place of previous delivery (AOR=3.926, 95%CI 1.023-15.063), recognizing pregnancy through missed period(AOR= 3.631, 95% CI 1.520-8.674), pregnancy related pain(AOR= 3.499, 95% CI 1.423 - 8.603) and lack of family support (AOR=2.647, 95% CI 1.092-6.415) were determinants of late ANC initiation.

ConclusionBeing age > 25 years, poor knowledge about ANC, lack of history of abortion, place of previous delivery, recognizing pregnancy through missed period, pregnancy related pain, and lack of family support during ANC booking were determinants of late ANC initiation.Health facilities and respective health care providers should provide health education at facility level regularly with due attention to late ANC initiation.